Tonix Pharma (TNXP) Tops Q3 EPS by 270c

Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($0.23), $2.70 better than the analyst estimate of ($2.93). Revenue for the quarter came in at $2.82 million versus the consensus estimate of $3.08 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Raymond James Starts Tonix Pharma (TNXP) at Strong Buy
• IBM unveils sub-1 nanometer chip with new 3D transistor design
• SINTX Technologies (SINT) files for 5.82M share offering by selling stockholders